 |
||||
|
||||
|
||||
|
||||
Previous Article | Next Article
The Journal of Neuroscience, February 1, 2000, 20(3):1249-1259
The Analgesic Effects of Supraspinal µ and
Opioid Receptor Agonists Are Potentiated during Persistent Inflammation
Robert W. Hurley and Donna L. Hammond Department of Anesthesia and Critical Care and The Committee on Neurobiology, University of Chicago, Chicago, Illinois 60637
This study examined the antihyperalgesic and antinociceptive effects of opioid receptor agonists microinjected in the rostral ventromedial medulla (RVM) of rats 4 hr, 4 d, and 2 weeks after the induction of an inflammatory injury by injection of complete Freund's adjuvant (CFA) in one hindpaw. Nociceptive sensitivity of the ipsilateral, inflamed and the contralateral, uninflamed hindpaws was determined by the radiant-heat paw withdrawal test. The antihyperalgesic potency of the µ opioid receptor agonist [D-Ala2,N-Me-Phe4,Gly5-ol]enkephalin (DAMGO), determined for the inflamed hindpaw, was enhanced 4 d and 2 weeks after injury. The antinociceptive potency of DAMGO, determined for the contralateral, uninflamed hindpaw, was also progressively enhanced 4 hr, 4 d, and 2 weeks after injury. The magnitude of enhancement paralleled the chronicity of the injury. The greatest potentiation occurred 2 weeks after injury when the ED50 value of DAMGO in CFA-treated rats was one-tenth that in saline-treated rats. The antihyperalgesic and antinociceptive effects of the
opioid receptor agonist [D-Ala2,Glu4]deltorphin were also increased 2 weeks after injury. These results indicate that peripheral inflammatory injury alters the pharmacology of excitatory and inhibitory inputs that modulate the activity of RVM neurons in such a manner as to enhance the effects of opioid agonists in this region. These changes have ramifications not only for the alleviation of hyperalgesia at the site of injury but also for opioid-induced antinociception at sites remote to the injury as revealed by increases in the potency of opioid agonists to suppress nociceptive responses of the contralateral, uninflamed hindpaw.
Key words: µ opioid receptor;
Copyright © 2000 Society for Neuroscience 0270-6474/00/2031249-11$05.00/0
This article has been cited by other articles:
K. M. Hellman, T. S. Brink, and P. Mason
Activity of Murine Raphe Magnus Cells Predicts Tachypnea and On-Going Nociceptive Responsiveness
J Neurophysiol, December 1, 2007; 98(6): 3121 - 3133.
[Abstract] [Full Text] [PDF]
K. T. Sykes, S. R. White, R. W. Hurley, H. Mizoguchi, L. F. Tseng, and D. L. Hammond
Mechanisms Responsible for the Enhanced Antinociceptive Effects of {micro}-Opioid Receptor Agonists in the Rostral Ventromedial Medulla of Male Rats with Persistent Inflammatory Pain
J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 813 - 821.
[Abstract] [Full Text] [PDF]
R. Benoliel, J. Epstein, E. Eliav, R. Jurevic, and S. Elad
Orofacial Pain in Cancer: Part I--Mechanisms
J. Dent. Res., June 1, 2007; 86(6): 491 - 505.
[Abstract] [Full Text] [PDF]
X. Wang, R. J. Traub, and A. Z. Murphy
Persistent pain model reveals sex difference in morphine potency
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2006; 291(2): R300 - R306.
[Abstract] [Full Text] [PDF]
Y. Guan, J. Borzan, R. A. Meyer, and S. N. Raja
Windup in dorsal horn neurons is modulated by endogenous spinal mu-opioid mechanisms.
J. Neurosci., April 19, 2006; 26(16): 4298 - 4307.
[Abstract] [Full Text] [PDF]
J. Ma, Y. Zhang, A. E. Kalyuzhny, and Z. Z. Pan
Emergence of Functional {delta}-Opioid Receptors Induced by Long-Term Treatment with Morphine
Mol. Pharmacol., April 1, 2006; 69(4): 1137 - 1145.
[Abstract] [Full Text] [PDF]
W. Kincaid, M. J. Neubert, M. Xu, C. J. Kim, and M. M. Heinricher
Role for Medullary Pain Facilitating Neurons in Secondary Thermal Hyperalgesia
J Neurophysiol, January 1, 2006; 95(1): 33 - 41.
[Abstract] [Full Text] [PDF]
O. Pol, J. R. Palacio, and M. M. Puig
The Expression of {delta}- and {kappa}-Opioid Receptor Is Enhanced during Intestinal Inflammation in Mice
J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 455 - 462.
[Abstract] [Full Text] [PDF]
K. Miki, Q.-Q. Zhou, W. Guo, Y. Guan, R. Terayama, R. Dubner, and K. Ren
Changes in Gene Expression and Neuronal Phenotype in Brain Stem Pain Modulatory Circuitry After Inflammation
J Neurophysiol, February 1, 2002; 87(2): 750 - 760.
[Abstract] [Full Text] [PDF]
Y. Guan, R. Terayama, R. Dubner, and K. Ren
Plasticity in Excitatory Amino Acid Receptor-Mediated Descending Pain Modulation after Inflammation
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 513 - 520.
[Abstract] [Full Text] [PDF]
I. Kissin, C. A. Bright, and E. L. Bradley Jr.
Can Inflammatory Pain Prevent the Development of Acute Tolerance to Alfentanil?
Anesth. Analg., May 1, 2001; 92(5): 1296 - 1300.
[Abstract] [Full Text] [PDF]
R. W. Hurley and D. L. Hammond
Contribution of Endogenous Enkephalins to the Enhanced Analgesic Effects of Supraspinal {micro} Opioid Receptor Agonists after Inflammatory Injury
J. Neurosci., April 1, 2001; 21(7): 2536 - 2545.
[Abstract] [Full Text] [PDF]
M. R. Brandt, M. S. Furness, N. K. Mello, K. C. Rice, and S. S. Negus
Antinociceptive Effects of {delta}-Opioid Agonists in Rhesus Monkeys: Effects on Chemically Induced Thermal Hypersensitivity
J. Pharmacol. Exp. Ther., March 1, 2001; 296(3): 939 - 946.
[Abstract] [Full Text]
H. Bester, C. De Felipe, and S. P. Hunt
The NK1 Receptor Is Essential for the Full Expression of Noxious Inhibitory Controls in the Mouse
J. Neurosci., February 1, 2001; 21(3): 1039 - 1046.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|